Symptom scores remained stable over time, with similar QOL trends in both treatment arms.

Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC ... baseline renal insufficiency, and significant comorbid ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the ...

in combination with nivolumab versus sunitinib in people living with previously untreated advanced renal cell carcinoma (aRCC). These final data demonstrated sustained superior efficacy benefits for ...

Thomas Hutson, DO, PharmD, discusses key takeaways from the phase 3 CLEAR trial evaluating lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma.

Metabolic dysregulation in the development of clear cell renal cell carcinoma (ccRCC) remains to be understood. Here the authors identify that a carnitine synthesis enzyme BBOX1, which inhibits ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...

non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form of kidney ... Sep. 18, 2024 — A team developed a human iPS cell-derived kidney organoid ...

Most tonsil cancers are a type called squamous cell carcinoma. A small number of tonsil cancers are lymphomas. The information in this section is about squamous cell carcinoma. The treatment for ...

Bisphosphonate therapy is generally well tolerated, but because intravenous bisphosphonates can cause decreased renal function, the US Food and Drug Administration (FDA) recommends renal ...